Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
41.36
-1.14 (-2.68%)
Jan 31, 2025, 4:00 PM EST - Market closed
Apogee Therapeutics Employees
Apogee Therapeutics had 91 employees as of December 31, 2023.
Employees
91
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,611,681
Market Cap
2.35B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 91 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
APGE News
- 3 days ago - Apogee Therapeutics to Participate at the Guggenheim SMID Cap Biotech Conference - GlobeNewsWire
- 2 months ago - Apogee Therapeutics Highlights Progress and Best-in-Class Potential of Novel Biologic Programs for I&I Diseases at 2024 Inaugural R&D Day - GlobeNewsWire
- 2 months ago - Apogee Therapeutics Announces Agenda for Virtual R&D Day - GlobeNewsWire
- 2 months ago - Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024 - GlobeNewsWire
- 2 months ago - Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic Dermatitis - Seeking Alpha
- 3 months ago - Apogee Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 3 months ago - Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting - GlobeNewsWire
- 5 months ago - Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - GlobeNewsWire